Error message

  • Deprecated function: Optional parameter $feed_nid declared before required parameter $context is implicitly treated as a required parameter in include_once() (line 1439 of /local/drupal/imat/includes/bootstrap.inc).
  • Deprecated function: Optional parameter $input declared before required parameter $form_state is implicitly treated as a required parameter in require_once() (line 12 of /local/drupal/imat/sites/all/modules/media/media.module).
  • Deprecated function: Optional parameter $base_table declared before required parameter $options is implicitly treated as a required parameter in include_once() (line 3542 of /local/drupal/imat/includes/bootstrap.inc).
  • Deprecated function: Optional parameter $base_field declared before required parameter $options is implicitly treated as a required parameter in include_once() (line 3542 of /local/drupal/imat/includes/bootstrap.inc).
×

You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2007 R43 CA126668 RFA-CA-07-008 GORDON, NEAL FRANCIS EPITOME BIOSYSTEMS, INC A STANDARDIZED ANTIBODY MICROARRAY-BASED SYSTEM FOR THE QUANTITATIVE MEASUREMENT Complete
2003 R43 CA103086 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. ITP-BASED SELECTIVE ENRICHMENT OF LOW ABUNDANCE PROTEINS Complete
2000 R43 CA086181 PAR-99-101 SERBEDZIJA, GEORGE N PHYLONIX PHARMACEUTICALS, INC. WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING Complete
2002 R43 CA097482 PAR-01-105 LATHAM, GARY J AMBION, INC. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA Complete
1999 R43 CA083382 PAR-98-066 MONFORTE, JOSEPH A GENETRACE SYSTEMS, INC. EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS Complete
2007 R43 CA126726 RFA-CA-07-008 MEDGHALCHI, SUSAN FASGEN, INC. FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER Complete
2014 R43 CA187852 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2020 R43 CA250885 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Active
2000 R43 CA086413 PAR-99-101 KOGON, ALEX A BIOLINX, LLC THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING Complete
2002 R43 CA097483 PAR-01-105 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER Complete
1999 R43 CA083384 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2007 R43 CA128752 RFA-CA-07-010 KRAVITZ, RACHEL HANNAH NEOCLONE BIOTECHNOLOGY INTERNATIONAL A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS Complete
2014 R43 CA188154 PAR-13-327 FELLMANN, CHRISTOF MIRIMUS, INC. RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO Complete
2000 R43 CA086755 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 CA097505 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2018 R43 CA236097 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
1999 R43 CA083385 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2000 R43 CA088381 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 CA097507 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2018 R43 CA236101 PAR-18-303 LEE, LY JAMES NANOMATERIAL INNOVATION, LTD Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis Complete
1999 R43 CA083388 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2017 R43 CA214386 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2000 R43 CA088396 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2018 R43 CA236142 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
1999 R43 CA083390 PAR-98-066 WIKTOR, PETER J. ENGINEERING ARTS PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2020 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2000 R43 CA088696 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2019 R43 CA236103 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 CA083396 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2019 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
1999 R43 CA083398 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2005 R43 CA112612 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete
2019 R43 CA236177 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
1999 R43 CA083402 PAR-98-066 BEACH, DAVID H. GENETICA, INC. TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS Complete
2005 R43 CA112735 RFA-CA-05-006 LU, CHIUNG-MEI GENACO BIOMEDICAL PRODUCTS, INC. EXPRESSION PROFILING OF MICRORNAS WITH BEAD ARRAY Complete
2019 R43 CA239967 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
1999 R43 CA083477 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2005 R43 CA113926 RFA-CA-05-006 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DETECTING INTEGRATED HPV DNA IN IMMUNOCOMPROMISED WOMEN Complete
2008 R43 CA128780 RFA-CA-07-039 TYRRELL, STEVEN PATRICK CONTROLLED PROCESS TECHNOLOGIES, LLC A RAPID SOLUTION-PHASE IMMUNOASSAY FOR PROTEOMICS Complete
2005 R43 CA114126 RFA-CA-05-006 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2008 R43 CA132049 RFA-CA-07-043 PAMULA, VAMSEE K ADVANCED LIQUID LOGIC MULTIPLEXING CANCER SAMPLE PREPARATION: INDIRECT IMMUNOMAGNETIC ENRICHMENT Complete
2005 R43 CA114194 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 CA132081 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2008 R43 CA132680 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2015 R43 CA187787 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2008 R43 CA132841 RFA-CA-07-041 CHENCHIK, ALEX CELLECTA, INC. ARRAY-ASSISTED INSERTIONAL MUTAGENESIS PLATFORM FOR FORWARD GENETICS OF CANCER Complete
2015 R43 CA192674 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2006 R43 CA116218 RFA-CA-06-006 BEAUDENON, SYLVIE LUCIE AMBION DIAGNOSTICS, INC. ONCOGENIC MICRORNAS IN HPV-INFECTED CERVICAL SAMPLES Complete
2008 R43 CA132851 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 CA161965 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®